| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.80▲ | 1.81▲ | 1.81▲ | 2.14▼ | 2.14▼ |
| MA10 | 1.83▼ | 1.82▼ | 1.87▼ | 2.23▼ | 2.36▼ |
| MA20 | 1.81▲ | 1.88▼ | 2.03▼ | 2.20▼ | 2.37▼ |
| MA50 | 1.82▼ | 2.10▼ | 2.23▼ | 2.46▼ | 1.99▼ |
| MA100 | 1.87▼ | 2.23▼ | 2.24▼ | 2.38▼ | 4.66▼ |
| MA200 | 2.02▼ | 2.24▼ | 2.15▼ | 2.20▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.010▲ | -0.014▼ | -0.019▼ | -0.081▼ |
| RSI | 50.094▲ | 33.381▼ | 29.554▼ | 32.506▼ | 42.678▼ |
| STOCH | 15.351▼ | 30.897 | 11.774▼ | 36.159 | 17.461▼ |
| WILL %R | -63.158 | -72.727 | -89.916▼ | -90.446▼ | -96.042▼ |
| CCI | -26.217 | -47.619 | -79.491 | -274.739▼ | -78.729 |
|
Thursday, May 07, 2026 05:22 AM
KOASTAL-2 and -3 studies evaluating navacaprant in major depressive disorder on track for joint topline readout in the second quarter of 2026 Progressing NMRA-511 in Alzheimer’s disease agitation and ...
|
|
Thursday, May 07, 2026 05:22 AM
KOASTAL-2 and -3 studies evaluating navacaprant in major depressive disorder on track for joint topline readout in the second quarter of 2026 Progressing NMRA-511 in Alzheimer’s disease agitation and ...
|
|
Monday, April 27, 2026 02:48 AM
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 1.97 | 1.98 | 1.755 | 1.83 | 2,128,664 |
| 07/05/26 | 2.33 | 2.36 | 1.90 | 1.94 | 2,743,010 |
| 06/05/26 | 2.32 | 2.42 | 2.27 | 2.33 | 1,708,831 |
| 05/05/26 | 2.36 | 2.405 | 2.23 | 2.30 | 693,229 |
| 04/05/26 | 2.44 | 2.48 | 2.29 | 2.31 | 1,227,542 |
| 01/05/26 | 2.47 | 2.54 | 2.33 | 2.44 | 3,495,927 |
| 30/04/26 | 2.29 | 2.51 | 2.23 | 2.47 | 1,218,837 |
| 29/04/26 | 2.24 | 2.37 | 2.20 | 2.25 | 1,138,768 |
| 28/04/26 | 2.22 | 2.30 | 2.16 | 2.25 | 2,052,344 |
| 27/04/26 | 2.25 | 2.31 | 2.18 | 2.22 | 951,957 |
|
|
||||
|
|
||||
|
|